nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—SRC—retina—Behcet's disease	0.00132	0.0023	CbGeAlD
Crizotinib—STK35—midbrain—Behcet's disease	0.00132	0.00229	CbGeAlD
Crizotinib—RPS6KB1—mammalian vulva—Behcet's disease	0.00132	0.00229	CbGeAlD
Crizotinib—MAP3K12—spinal cord—Behcet's disease	0.00131	0.00228	CbGeAlD
Crizotinib—ACVR1—spinal cord—Behcet's disease	0.00131	0.00228	CbGeAlD
Crizotinib—TBK1—cardiac atrium—Behcet's disease	0.00131	0.00228	CbGeAlD
Crizotinib—LCK—mammalian vulva—Behcet's disease	0.00131	0.00228	CbGeAlD
Crizotinib—FGR—mammalian vulva—Behcet's disease	0.00131	0.00228	CbGeAlD
Crizotinib—MAP3K3—skin of body—Behcet's disease	0.00131	0.00227	CbGeAlD
Crizotinib—AXL—mammalian vulva—Behcet's disease	0.0013	0.00227	CbGeAlD
Crizotinib—TYRO3—nervous system—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—FER—nervous system—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—ALK—nervous system—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—EPHA5—nervous system—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—TYK2—cardiac atrium—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—MAPK7—brain—Behcet's disease	0.0013	0.00226	CbGeAlD
Crizotinib—LYN—nervous system—Behcet's disease	0.00129	0.00225	CbGeAlD
Crizotinib—EPHA4—medulla oblongata—Behcet's disease	0.00129	0.00224	CbGeAlD
Crizotinib—EPHA8—brain—Behcet's disease	0.00129	0.00224	CbGeAlD
Crizotinib—FES—brain—Behcet's disease	0.00129	0.00224	CbGeAlD
Crizotinib—BMPR1B—nervous system—Behcet's disease	0.00128	0.00222	CbGeAlD
Crizotinib—MAP3K19—nervous system—Behcet's disease	0.00128	0.00222	CbGeAlD
Crizotinib—BMP2K—midbrain—Behcet's disease	0.00127	0.00221	CbGeAlD
Crizotinib—RPS6KB1—cardiac atrium—Behcet's disease	0.00126	0.00219	CbGeAlD
Crizotinib—SLK—mammalian vulva—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—EPHA5—central nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—FER—central nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—ALK—central nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—TYRO3—central nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—TNK2—nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—IGF1R—nervous system—Behcet's disease	0.00125	0.00218	CbGeAlD
Crizotinib—EPHB6—skin of body—Behcet's disease	0.00125	0.00217	CbGeAlD
Crizotinib—AXL—cardiac atrium—Behcet's disease	0.00125	0.00217	CbGeAlD
Crizotinib—LYN—central nervous system—Behcet's disease	0.00125	0.00217	CbGeAlD
Crizotinib—EPHB4—mammalian vulva—Behcet's disease	0.00125	0.00217	CbGeAlD
Crizotinib—BMP2K—spinal cord—Behcet's disease	0.00124	0.00215	CbGeAlD
Crizotinib—JAK2—mammalian vulva—Behcet's disease	0.00124	0.00215	CbGeAlD
Crizotinib—TBK1—medulla oblongata—Behcet's disease	0.00124	0.00215	CbGeAlD
Crizotinib—MAP3K19—central nervous system—Behcet's disease	0.00123	0.00214	CbGeAlD
Crizotinib—BMPR1B—central nervous system—Behcet's disease	0.00123	0.00214	CbGeAlD
Crizotinib—TYK2—medulla oblongata—Behcet's disease	0.00123	0.00213	CbGeAlD
Crizotinib—EPHA2—mammalian vulva—Behcet's disease	0.00122	0.00213	CbGeAlD
Crizotinib—TIE1—nervous system—Behcet's disease	0.00122	0.00212	CbGeAlD
Crizotinib—MET—brain—Behcet's disease	0.00122	0.00212	CbGeAlD
Crizotinib—RIPK2—midbrain—Behcet's disease	0.00122	0.00212	CbGeAlD
Crizotinib—TNK2—central nervous system—Behcet's disease	0.0012	0.00209	CbGeAlD
Crizotinib—IGF1R—central nervous system—Behcet's disease	0.0012	0.00209	CbGeAlD
Crizotinib—SLK—cardiac atrium—Behcet's disease	0.0012	0.00209	CbGeAlD
Crizotinib—CSF1R—eye—Behcet's disease	0.0012	0.00208	CbGeAlD
Crizotinib—EPHB4—cardiac atrium—Behcet's disease	0.00119	0.00207	CbGeAlD
Crizotinib—MAP4K5—mammalian vulva—Behcet's disease	0.00119	0.00207	CbGeAlD
Crizotinib—MAP3K3—mammalian vulva—Behcet's disease	0.00119	0.00207	CbGeAlD
Crizotinib—RPS6KB1—medulla oblongata—Behcet's disease	0.00119	0.00207	CbGeAlD
Crizotinib—RIPK2—spinal cord—Behcet's disease	0.00119	0.00206	CbGeAlD
Crizotinib—AURKA—nervous system—Behcet's disease	0.00119	0.00206	CbGeAlD
Crizotinib—JAK2—cardiac atrium—Behcet's disease	0.00118	0.00206	CbGeAlD
Crizotinib—AXL—medulla oblongata—Behcet's disease	0.00118	0.00205	CbGeAlD
Crizotinib—CDK7—brain—Behcet's disease	0.00118	0.00205	CbGeAlD
Crizotinib—TESK1—nervous system—Behcet's disease	0.00118	0.00205	CbGeAlD
Crizotinib—TIE1—central nervous system—Behcet's disease	0.00117	0.00204	CbGeAlD
Crizotinib—EPHA2—cardiac atrium—Behcet's disease	0.00117	0.00204	CbGeAlD
Crizotinib—TAOK2—brain—Behcet's disease	0.00117	0.00203	CbGeAlD
Crizotinib—SRC—skin of body—Behcet's disease	0.00116	0.00202	CbGeAlD
Crizotinib—MERTK—nervous system—Behcet's disease	0.00114	0.00199	CbGeAlD
Crizotinib—AURKA—central nervous system—Behcet's disease	0.00114	0.00199	CbGeAlD
Crizotinib—MAP4K5—cardiac atrium—Behcet's disease	0.00114	0.00199	CbGeAlD
Crizotinib—TEK—cardiac atrium—Behcet's disease	0.00114	0.00199	CbGeAlD
Crizotinib—MAP3K3—cardiac atrium—Behcet's disease	0.00114	0.00199	CbGeAlD
Crizotinib—EPHB6—mammalian vulva—Behcet's disease	0.00114	0.00198	CbGeAlD
Crizotinib—SLK—medulla oblongata—Behcet's disease	0.00113	0.00197	CbGeAlD
Crizotinib—TESK1—central nervous system—Behcet's disease	0.00113	0.00197	CbGeAlD
Crizotinib—TBK1—midbrain—Behcet's disease	0.00113	0.00196	CbGeAlD
Crizotinib—PTK2—midbrain—Behcet's disease	0.00113	0.00196	CbGeAlD
Crizotinib—EPHB4—medulla oblongata—Behcet's disease	0.00112	0.00196	CbGeAlD
Crizotinib—ACVR1B—brain—Behcet's disease	0.00112	0.00196	CbGeAlD
Crizotinib—EPHA3—brain—Behcet's disease	0.00112	0.00196	CbGeAlD
Crizotinib—TYK2—midbrain—Behcet's disease	0.00112	0.00195	CbGeAlD
Crizotinib—LIMK2—nervous system—Behcet's disease	0.00112	0.00195	CbGeAlD
Crizotinib—JAK2—medulla oblongata—Behcet's disease	0.00112	0.00194	CbGeAlD
Crizotinib—IRAK1—midbrain—Behcet's disease	0.00111	0.00193	CbGeAlD
Crizotinib—ACVR1—nervous system—Behcet's disease	0.00111	0.00193	CbGeAlD
Crizotinib—MAP3K12—nervous system—Behcet's disease	0.00111	0.00193	CbGeAlD
Crizotinib—TBK1—spinal cord—Behcet's disease	0.0011	0.00192	CbGeAlD
Crizotinib—PTK2—spinal cord—Behcet's disease	0.0011	0.00192	CbGeAlD
Crizotinib—MERTK—central nervous system—Behcet's disease	0.0011	0.00192	CbGeAlD
Crizotinib—YES1—mammalian vulva—Behcet's disease	0.0011	0.00191	CbGeAlD
Crizotinib—TYK2—spinal cord—Behcet's disease	0.00109	0.0019	CbGeAlD
Crizotinib—STK10—mammalian vulva—Behcet's disease	0.00109	0.0019	CbGeAlD
Crizotinib—EPHB6—cardiac atrium—Behcet's disease	0.00109	0.0019	CbGeAlD
Crizotinib—TAOK3—mammalian vulva—Behcet's disease	0.00109	0.00189	CbGeAlD
Crizotinib—RPS6KB1—midbrain—Behcet's disease	0.00109	0.00189	CbGeAlD
Crizotinib—STK35—nervous system—Behcet's disease	0.00108	0.00189	CbGeAlD
Crizotinib—LIMK2—central nervous system—Behcet's disease	0.00108	0.00187	CbGeAlD
Crizotinib—TEK—medulla oblongata—Behcet's disease	0.00108	0.00187	CbGeAlD
Crizotinib—MAP3K3—medulla oblongata—Behcet's disease	0.00108	0.00187	CbGeAlD
Crizotinib—MAP4K5—medulla oblongata—Behcet's disease	0.00108	0.00187	CbGeAlD
Crizotinib—AXL—midbrain—Behcet's disease	0.00108	0.00187	CbGeAlD
Crizotinib—JAK3—brain—Behcet's disease	0.00107	0.00187	CbGeAlD
Crizotinib—EPHA6—brain—Behcet's disease	0.00107	0.00187	CbGeAlD
Crizotinib—DCLK1—brain—Behcet's disease	0.00107	0.00185	CbGeAlD
Crizotinib—ACVR1—central nervous system—Behcet's disease	0.00107	0.00185	CbGeAlD
Crizotinib—MAP3K12—central nervous system—Behcet's disease	0.00107	0.00185	CbGeAlD
Crizotinib—RPS6KB1—spinal cord—Behcet's disease	0.00106	0.00184	CbGeAlD
Crizotinib—PLK4—brain—Behcet's disease	0.00106	0.00184	CbGeAlD
Crizotinib—YES1—cardiac atrium—Behcet's disease	0.00105	0.00183	CbGeAlD
Crizotinib—STK4—brain—Behcet's disease	0.00105	0.00183	CbGeAlD
Crizotinib—AXL—spinal cord—Behcet's disease	0.00105	0.00182	CbGeAlD
Crizotinib—STK35—central nervous system—Behcet's disease	0.00104	0.00182	CbGeAlD
Crizotinib—BMP2K—nervous system—Behcet's disease	0.00104	0.00182	CbGeAlD
Crizotinib—CSF1R—skin of body—Behcet's disease	0.00104	0.00181	CbGeAlD
Crizotinib—TAOK3—cardiac atrium—Behcet's disease	0.00104	0.00181	CbGeAlD
Crizotinib—SLK—midbrain—Behcet's disease	0.00103	0.0018	CbGeAlD
Crizotinib—EPHB6—medulla oblongata—Behcet's disease	0.00103	0.00179	CbGeAlD
Crizotinib—EPHB4—midbrain—Behcet's disease	0.00103	0.00179	CbGeAlD
Crizotinib—SRC—cardiac atrium—Behcet's disease	0.00101	0.00176	CbGeAlD
Crizotinib—SLK—spinal cord—Behcet's disease	0.00101	0.00176	CbGeAlD
Crizotinib—PTK2B—nervous system—Behcet's disease	0.00101	0.00175	CbGeAlD
Crizotinib—BMP2K—central nervous system—Behcet's disease	0.001	0.00175	CbGeAlD
Crizotinib—EPHB4—spinal cord—Behcet's disease	0.001	0.00174	CbGeAlD
Crizotinib—JAK2—spinal cord—Behcet's disease	0.000995	0.00173	CbGeAlD
Crizotinib—ALK—brain—Behcet's disease	0.000995	0.00173	CbGeAlD
Crizotinib—FER—brain—Behcet's disease	0.000995	0.00173	CbGeAlD
Crizotinib—EPHA5—brain—Behcet's disease	0.000995	0.00173	CbGeAlD
Crizotinib—TYRO3—brain—Behcet's disease	0.000995	0.00173	CbGeAlD
Crizotinib—YES1—medulla oblongata—Behcet's disease	0.000994	0.00173	CbGeAlD
Crizotinib—LYN—brain—Behcet's disease	0.00099	0.00172	CbGeAlD
Crizotinib—TNK1—brain—Behcet's disease	0.000985	0.00171	CbGeAlD
Crizotinib—MAP4K5—midbrain—Behcet's disease	0.000983	0.00171	CbGeAlD
Crizotinib—MAP3K3—midbrain—Behcet's disease	0.000983	0.00171	CbGeAlD
Crizotinib—TEK—midbrain—Behcet's disease	0.000983	0.00171	CbGeAlD
Crizotinib—TAOK3—medulla oblongata—Behcet's disease	0.000981	0.00171	CbGeAlD
Crizotinib—MAP4K1—brain—Behcet's disease	0.000975	0.0017	CbGeAlD
Crizotinib—BMPR1B—brain—Behcet's disease	0.000975	0.0017	CbGeAlD
Crizotinib—MAP3K19—brain—Behcet's disease	0.000975	0.0017	CbGeAlD
Crizotinib—ABL1—brainstem—Behcet's disease	0.000973	0.00169	CbGeAlD
Crizotinib—PTK2B—central nervous system—Behcet's disease	0.00097	0.00169	CbGeAlD
Crizotinib—EPHA4—nervous system—Behcet's disease	0.000966	0.00168	CbGeAlD
Crizotinib—MAP4K5—spinal cord—Behcet's disease	0.000959	0.00167	CbGeAlD
Crizotinib—MAP3K3—spinal cord—Behcet's disease	0.000959	0.00167	CbGeAlD
Crizotinib—TEK—spinal cord—Behcet's disease	0.000959	0.00167	CbGeAlD
Crizotinib—TNK2—brain—Behcet's disease	0.000956	0.00166	CbGeAlD
Crizotinib—IGF1R—brain—Behcet's disease	0.000956	0.00166	CbGeAlD
Crizotinib—CSF1R—mammalian vulva—Behcet's disease	0.000951	0.00165	CbGeAlD
Crizotinib—MAP3K2—nervous system—Behcet's disease	0.000948	0.00165	CbGeAlD
Crizotinib—ABL1—eye—Behcet's disease	0.000947	0.00165	CbGeAlD
Crizotinib—MAP4K2—brain—Behcet's disease	0.000942	0.00164	CbGeAlD
Crizotinib—EPHB6—midbrain—Behcet's disease	0.00094	0.00163	CbGeAlD
Crizotinib—ABL1—retina—Behcet's disease	0.000939	0.00163	CbGeAlD
Crizotinib—EPHA4—central nervous system—Behcet's disease	0.00093	0.00162	CbGeAlD
Crizotinib—STK3—brain—Behcet's disease	0.00093	0.00162	CbGeAlD
Crizotinib—TIE1—brain—Behcet's disease	0.00093	0.00162	CbGeAlD
Crizotinib—TBK1—nervous system—Behcet's disease	0.000928	0.00161	CbGeAlD
Crizotinib—PTK2—nervous system—Behcet's disease	0.000928	0.00161	CbGeAlD
Crizotinib—TYK2—nervous system—Behcet's disease	0.000922	0.0016	CbGeAlD
Crizotinib—EPHB6—spinal cord—Behcet's disease	0.000917	0.00159	CbGeAlD
Crizotinib—MAP3K2—central nervous system—Behcet's disease	0.000912	0.00159	CbGeAlD
Crizotinib—CSF1R—cardiac atrium—Behcet's disease	0.00091	0.00158	CbGeAlD
Crizotinib—YES1—midbrain—Behcet's disease	0.000908	0.00158	CbGeAlD
Crizotinib—AURKA—brain—Behcet's disease	0.000906	0.00158	CbGeAlD
Crizotinib—TESK1—brain—Behcet's disease	0.000899	0.00156	CbGeAlD
Crizotinib—TAOK3—midbrain—Behcet's disease	0.000896	0.00156	CbGeAlD
Crizotinib—PTK2—central nervous system—Behcet's disease	0.000894	0.00155	CbGeAlD
Crizotinib—TBK1—central nervous system—Behcet's disease	0.000894	0.00155	CbGeAlD
Crizotinib—RPS6KB1—nervous system—Behcet's disease	0.000893	0.00155	CbGeAlD
Crizotinib—TYK2—central nervous system—Behcet's disease	0.000888	0.00154	CbGeAlD
Crizotinib—FGR—nervous system—Behcet's disease	0.000887	0.00154	CbGeAlD
Crizotinib—YES1—spinal cord—Behcet's disease	0.000886	0.00154	CbGeAlD
Crizotinib—AXL—nervous system—Behcet's disease	0.000884	0.00154	CbGeAlD
Crizotinib—TAOK3—spinal cord—Behcet's disease	0.000875	0.00152	CbGeAlD
Crizotinib—MERTK—brain—Behcet's disease	0.000874	0.00152	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—Behcet's disease	0.00086	0.0015	CbGeAlD
Crizotinib—CSF1R—medulla oblongata—Behcet's disease	0.000858	0.00149	CbGeAlD
Crizotinib—LIMK2—brain—Behcet's disease	0.000855	0.00149	CbGeAlD
Crizotinib—FGR—central nervous system—Behcet's disease	0.000854	0.00149	CbGeAlD
Crizotinib—SRC—spinal cord—Behcet's disease	0.000852	0.00148	CbGeAlD
Crizotinib—NUAK2—brain—Behcet's disease	0.000852	0.00148	CbGeAlD
Crizotinib—AXL—central nervous system—Behcet's disease	0.000851	0.00148	CbGeAlD
Crizotinib—MAP3K12—brain—Behcet's disease	0.000846	0.00147	CbGeAlD
Crizotinib—ACVR1—brain—Behcet's disease	0.000846	0.00147	CbGeAlD
Crizotinib—JAK2—nervous system—Behcet's disease	0.000839	0.00146	CbGeAlD
Crizotinib—STK35—brain—Behcet's disease	0.000829	0.00144	CbGeAlD
Crizotinib—EPHA2—nervous system—Behcet's disease	0.000829	0.00144	CbGeAlD
Crizotinib—ABL1—skin of body—Behcet's disease	0.000824	0.00143	CbGeAlD
Crizotinib—TEK—nervous system—Behcet's disease	0.000808	0.00141	CbGeAlD
Crizotinib—MAP3K3—nervous system—Behcet's disease	0.000808	0.00141	CbGeAlD
Crizotinib—MAP4K5—nervous system—Behcet's disease	0.000808	0.00141	CbGeAlD
Crizotinib—ABL2—brain—Behcet's disease	0.000808	0.0014	CbGeAlD
Crizotinib—JAK2—central nervous system—Behcet's disease	0.000807	0.0014	CbGeAlD
Crizotinib—EPHA2—central nervous system—Behcet's disease	0.000798	0.00139	CbGeAlD
Crizotinib—BMP2K—brain—Behcet's disease	0.000798	0.00139	CbGeAlD
Crizotinib—CSF1R—midbrain—Behcet's disease	0.000784	0.00136	CbGeAlD
Crizotinib—MAP4K5—central nervous system—Behcet's disease	0.000778	0.00135	CbGeAlD
Crizotinib—MAP3K3—central nervous system—Behcet's disease	0.000778	0.00135	CbGeAlD
Crizotinib—TEK—central nervous system—Behcet's disease	0.000778	0.00135	CbGeAlD
Crizotinib—EPHB6—nervous system—Behcet's disease	0.000773	0.00134	CbGeAlD
Crizotinib—PTK2B—brain—Behcet's disease	0.00077	0.00134	CbGeAlD
Crizotinib—CSF1R—spinal cord—Behcet's disease	0.000765	0.00133	CbGeAlD
Crizotinib—RIPK2—brain—Behcet's disease	0.000764	0.00133	CbGeAlD
Crizotinib—ABL1—mammalian vulva—Behcet's disease	0.000751	0.00131	CbGeAlD
Crizotinib—YES1—nervous system—Behcet's disease	0.000747	0.0013	CbGeAlD
Crizotinib—EPHB6—central nervous system—Behcet's disease	0.000744	0.00129	CbGeAlD
Crizotinib—STK10—nervous system—Behcet's disease	0.00074	0.00129	CbGeAlD
Crizotinib—EPHA4—brain—Behcet's disease	0.000739	0.00128	CbGeAlD
Crizotinib—TAOK3—nervous system—Behcet's disease	0.000737	0.00128	CbGeAlD
Crizotinib—MAP3K2—brain—Behcet's disease	0.000724	0.00126	CbGeAlD
Crizotinib—ABL1—cardiac atrium—Behcet's disease	0.00072	0.00125	CbGeAlD
Crizotinib—YES1—central nervous system—Behcet's disease	0.000719	0.00125	CbGeAlD
Crizotinib—SRC—nervous system—Behcet's disease	0.000718	0.00125	CbGeAlD
Crizotinib—STK10—central nervous system—Behcet's disease	0.000712	0.00124	CbGeAlD
Crizotinib—TAOK3—central nervous system—Behcet's disease	0.00071	0.00123	CbGeAlD
Crizotinib—PTK2—brain—Behcet's disease	0.000709	0.00123	CbGeAlD
Crizotinib—TBK1—brain—Behcet's disease	0.000709	0.00123	CbGeAlD
Crizotinib—TYK2—brain—Behcet's disease	0.000705	0.00123	CbGeAlD
Crizotinib—IRAK1—brain—Behcet's disease	0.000695	0.00121	CbGeAlD
Crizotinib—SRC—central nervous system—Behcet's disease	0.000691	0.0012	CbGeAlD
Crizotinib—RPS6KB1—brain—Behcet's disease	0.000682	0.00119	CbGeAlD
Crizotinib—ABL1—medulla oblongata—Behcet's disease	0.000678	0.00118	CbGeAlD
Crizotinib—FGR—brain—Behcet's disease	0.000678	0.00118	CbGeAlD
Crizotinib—AXL—brain—Behcet's disease	0.000676	0.00118	CbGeAlD
Crizotinib—SLK—brain—Behcet's disease	0.00065	0.00113	CbGeAlD
Crizotinib—EPHB4—brain—Behcet's disease	0.000646	0.00112	CbGeAlD
Crizotinib—CSF1R—nervous system—Behcet's disease	0.000645	0.00112	CbGeAlD
Crizotinib—JAK2—brain—Behcet's disease	0.000641	0.00112	CbGeAlD
Crizotinib—EPHA2—brain—Behcet's disease	0.000633	0.0011	CbGeAlD
Crizotinib—CSF1R—central nervous system—Behcet's disease	0.000621	0.00108	CbGeAlD
Crizotinib—ABL1—midbrain—Behcet's disease	0.00062	0.00108	CbGeAlD
Crizotinib—TEK—brain—Behcet's disease	0.000618	0.00107	CbGeAlD
Crizotinib—MAP3K3—brain—Behcet's disease	0.000618	0.00107	CbGeAlD
Crizotinib—MAP4K5—brain—Behcet's disease	0.000618	0.00107	CbGeAlD
Crizotinib—ABL1—spinal cord—Behcet's disease	0.000605	0.00105	CbGeAlD
Crizotinib—EPHB6—brain—Behcet's disease	0.00059	0.00103	CbGeAlD
Crizotinib—YES1—brain—Behcet's disease	0.000571	0.000993	CbGeAlD
Crizotinib—STK10—brain—Behcet's disease	0.000565	0.000984	CbGeAlD
Crizotinib—TAOK3—brain—Behcet's disease	0.000563	0.00098	CbGeAlD
Crizotinib—ABCB1—blood vessel—Behcet's disease	0.000553	0.000963	CbGeAlD
Crizotinib—SRC—brain—Behcet's disease	0.000549	0.000955	CbGeAlD
Crizotinib—ABL1—nervous system—Behcet's disease	0.00051	0.000887	CbGeAlD
Crizotinib—CSF1R—brain—Behcet's disease	0.000493	0.000857	CbGeAlD
Crizotinib—ABL1—central nervous system—Behcet's disease	0.000491	0.000854	CbGeAlD
Crizotinib—ABL1—brain—Behcet's disease	0.00039	0.000678	CbGeAlD
Crizotinib—ABCB1—retina—Behcet's disease	0.000292	0.000508	CbGeAlD
Crizotinib—ABCB1—mammalian vulva—Behcet's disease	0.000234	0.000406	CbGeAlD
Crizotinib—CYP3A4—nervous system—Behcet's disease	0.000224	0.000389	CbGeAlD
Crizotinib—CYP3A4—central nervous system—Behcet's disease	0.000216	0.000375	CbGeAlD
Crizotinib—ABCB1—medulla oblongata—Behcet's disease	0.000211	0.000367	CbGeAlD
Crizotinib—ABCB1—midbrain—Behcet's disease	0.000193	0.000335	CbGeAlD
Crizotinib—ABCB1—spinal cord—Behcet's disease	0.000188	0.000327	CbGeAlD
Crizotinib—ABCB1—nervous system—Behcet's disease	0.000158	0.000276	CbGeAlD
Crizotinib—ABCB1—central nervous system—Behcet's disease	0.000153	0.000265	CbGeAlD
Crizotinib—LCK—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000138	0.000324	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—APOA1—Behcet's disease	0.000138	0.000324	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—SERPINE1—Behcet's disease	0.000138	0.000324	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—NOS3—Behcet's disease	0.000138	0.000324	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—APOB—Behcet's disease	0.000137	0.000323	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—TNF—Behcet's disease	0.000137	0.000323	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—CXCL8—Behcet's disease	0.000137	0.000322	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000137	0.000321	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ITGB2—Behcet's disease	0.000137	0.000321	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCR1—Behcet's disease	0.000135	0.000317	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCR1—Behcet's disease	0.000133	0.000313	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—TNF—Behcet's disease	0.000132	0.00031	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—NOS3—Behcet's disease	0.000132	0.00031	CbGpPWpGaD
Crizotinib—LYN—Immune System—ITGAL—Behcet's disease	0.000132	0.00031	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—NOS3—Behcet's disease	0.000131	0.000309	CbGpPWpGaD
Crizotinib—ABL1—Immune System—ITGAL—Behcet's disease	0.000131	0.000308	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-B—Behcet's disease	0.00013	0.000306	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—APOB—Behcet's disease	0.000129	0.000304	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCR1—Behcet's disease	0.000126	0.000297	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—APOA1—Behcet's disease	0.000126	0.000296	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—APOB—Behcet's disease	0.000126	0.000296	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000124	0.000291	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—APOB—Behcet's disease	0.000123	0.00029	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CTLA4—Behcet's disease	0.000123	0.00029	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ITGAL—Behcet's disease	0.000123	0.00029	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCR1—Behcet's disease	0.000122	0.000288	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CTLA4—Behcet's disease	0.000122	0.000288	CbGpPWpGaD
Crizotinib—SRC—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000122	0.000287	CbGpPWpGaD
Crizotinib—YES1—Immune System—CTLA4—Behcet's disease	0.000121	0.000286	CbGpPWpGaD
Crizotinib—CDK7—Disease—APOB—Behcet's disease	0.000121	0.000286	CbGpPWpGaD
Crizotinib—ABCB1—brain—Behcet's disease	0.000121	0.000211	CbGeAlD
Crizotinib—YES1—Adaptive Immune System—ICAM1—Behcet's disease	0.00012	0.000283	CbGpPWpGaD
Crizotinib—LCK—Immune System—ITGB2—Behcet's disease	0.00012	0.000281	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—SERPINE1—Behcet's disease	0.000118	0.000277	CbGpPWpGaD
Crizotinib—TBK1—Immune System—ICAM1—Behcet's disease	0.000117	0.000275	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—CXCL8—Behcet's disease	0.000117	0.000274	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—SERPINE1—Behcet's disease	0.000116	0.000274	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-B—Behcet's disease	0.000116	0.000273	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—SERPINE1—Behcet's disease	0.000115	0.000271	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—SERPINE1—Behcet's disease	0.000115	0.000271	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CTLA4—Behcet's disease	0.000115	0.000271	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—HLA-B—Behcet's disease	0.000115	0.000271	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000114	0.000269	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-B—Behcet's disease	0.000114	0.000269	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TNF—Behcet's disease	0.000114	0.000269	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—APOB—Behcet's disease	0.000113	0.000266	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—NOS3—Behcet's disease	0.000113	0.000265	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—ICAM1—Behcet's disease	0.000112	0.000264	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CTLA4—Behcet's disease	0.000112	0.000263	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-B—Behcet's disease	0.000112	0.000263	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-B—Behcet's disease	0.000111	0.000262	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—NOS3—Behcet's disease	0.000111	0.000261	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000111	0.000261	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—CXCL8—Behcet's disease	0.000111	0.000261	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-B—Behcet's disease	0.00011	0.00026	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—NOS3—Behcet's disease	0.00011	0.000259	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—NOS3—Behcet's disease	0.00011	0.000259	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—APOA1—Behcet's disease	0.00011	0.000259	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—SERPINE1—Behcet's disease	0.000109	0.000257	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—APOA1—Behcet's disease	0.000109	0.000257	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000109	0.000256	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CTLA4—Behcet's disease	0.000108	0.000255	CbGpPWpGaD
Crizotinib—LCK—Immune System—ITGAL—Behcet's disease	0.000108	0.000254	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—HLA-B—Behcet's disease	0.000108	0.000253	CbGpPWpGaD
Crizotinib—SRC—Immune System—ITGB2—Behcet's disease	0.000106	0.000249	CbGpPWpGaD
Crizotinib—JAK3—Immune System—ICAM1—Behcet's disease	0.000106	0.000249	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—NOS3—Behcet's disease	0.000104	0.000246	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—APOA1—Behcet's disease	0.000102	0.00024	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—APOB—Behcet's disease	0.0001	0.000236	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—SERPINE1—Behcet's disease	0.0001	0.000235	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—APOA1—Behcet's disease	9.96e-05	0.000234	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCR1—Behcet's disease	9.92e-05	0.000233	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—CXCL8—Behcet's disease	9.77e-05	0.00023	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—CXCL8—Behcet's disease	9.77e-05	0.00023	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—APOA1—Behcet's disease	9.75e-05	0.000229	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TNF—Behcet's disease	9.7e-05	0.000228	CbGpPWpGaD
Crizotinib—CDK7—Disease—APOA1—Behcet's disease	9.61e-05	0.000226	CbGpPWpGaD
Crizotinib—SRC—Immune System—ITGAL—Behcet's disease	9.55e-05	0.000225	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—NOS3—Behcet's disease	9.55e-05	0.000225	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—ICAM1—Behcet's disease	9.43e-05	0.000222	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—HLA-B—Behcet's disease	9.43e-05	0.000222	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—ICAM1—Behcet's disease	9.3e-05	0.000219	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR1—Behcet's disease	9.28e-05	0.000218	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—CXCL8—Behcet's disease	9.26e-05	0.000218	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-B—Behcet's disease	9.11e-05	0.000214	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APOB—Behcet's disease	9.1e-05	0.000214	CbGpPWpGaD
Crizotinib—BLK—Immune System—ICAM1—Behcet's disease	9.07e-05	0.000213	CbGpPWpGaD
Crizotinib—LYN—Immune System—CTLA4—Behcet's disease	9.06e-05	0.000213	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	9.05e-05	0.000213	CbGpPWpGaD
Crizotinib—FGR—Immune System—ICAM1—Behcet's disease	9.04e-05	0.000213	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—CXCL8—Behcet's disease	9.02e-05	0.000212	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CTLA4—Behcet's disease	9.01e-05	0.000212	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-B—Behcet's disease	8.98e-05	0.000211	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—ICAM1—Behcet's disease	8.97e-05	0.000211	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—APOA1—Behcet's disease	8.95e-05	0.000211	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SERPINE1—Behcet's disease	8.74e-05	0.000206	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—SERPINE1—Behcet's disease	8.67e-05	0.000204	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	8.63e-05	0.000203	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-B—Behcet's disease	8.52e-05	0.0002	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CTLA4—Behcet's disease	8.48e-05	0.000199	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—CXCL8—Behcet's disease	8.47e-05	0.000199	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—NOS3—Behcet's disease	8.35e-05	0.000196	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—HLA-B—Behcet's disease	8.35e-05	0.000196	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—NOS3—Behcet's disease	8.28e-05	0.000195	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-B—Behcet's disease	8.27e-05	0.000195	CbGpPWpGaD
Crizotinib—TYK2—Disease—APOB—Behcet's disease	8.25e-05	0.000194	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—NOS3—Behcet's disease	8.24e-05	0.000194	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—SERPINE1—Behcet's disease	8.21e-05	0.000193	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—CXCL8—Behcet's disease	8.19e-05	0.000193	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR1—Behcet's disease	8.13e-05	0.000191	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—SERPINE1—Behcet's disease	8.12e-05	0.000191	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APOB—Behcet's disease	8.11e-05	0.000191	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	8.09e-05	0.00019	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-B—Behcet's disease	8.01e-05	0.000189	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APOB—Behcet's disease	8e-05	0.000188	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—APOA1—Behcet's disease	7.93e-05	0.000186	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SERPINE1—Behcet's disease	7.91e-05	0.000186	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—NOS3—Behcet's disease	7.75e-05	0.000182	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SERPINE1—Behcet's disease	7.74e-05	0.000182	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APOB—Behcet's disease	7.65e-05	0.00018	CbGpPWpGaD
Crizotinib—CDK7—Disease—SERPINE1—Behcet's disease	7.63e-05	0.000179	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—NOS3—Behcet's disease	7.55e-05	0.000178	CbGpPWpGaD
Crizotinib—LCK—Immune System—CTLA4—Behcet's disease	7.42e-05	0.000175	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APOB—Behcet's disease	7.42e-05	0.000175	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—CXCL8—Behcet's disease	7.4e-05	0.000174	CbGpPWpGaD
Crizotinib—PTK2—Immune System—ICAM1—Behcet's disease	7.4e-05	0.000174	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—NOS3—Behcet's disease	7.39e-05	0.000174	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	7.36e-05	0.000173	CbGpPWpGaD
Crizotinib—YES1—Immune System—ICAM1—Behcet's disease	7.3e-05	0.000172	CbGpPWpGaD
Crizotinib—CDK7—Disease—NOS3—Behcet's disease	7.28e-05	0.000171	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APOA1—Behcet's disease	7.2e-05	0.000169	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR1—Behcet's disease	7.2e-05	0.000169	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—SERPINE1—Behcet's disease	7.11e-05	0.000167	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TNF—Behcet's disease	7.09e-05	0.000167	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TNF—Behcet's disease	6.99e-05	0.000164	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—ICAM1—Behcet's disease	6.92e-05	0.000163	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—NOS3—Behcet's disease	6.79e-05	0.00016	CbGpPWpGaD
Crizotinib—TYK2—Immune System—ICAM1—Behcet's disease	6.72e-05	0.000158	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-B—Behcet's disease	6.7e-05	0.000158	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CXCL8—Behcet's disease	6.7e-05	0.000157	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-B—Behcet's disease	6.67e-05	0.000157	CbGpPWpGaD
Crizotinib—SRC—Immune System—CTLA4—Behcet's disease	6.57e-05	0.000155	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CXCL8—Behcet's disease	6.55e-05	0.000154	CbGpPWpGaD
Crizotinib—TYK2—Disease—APOA1—Behcet's disease	6.53e-05	0.000154	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—ICAM1—Behcet's disease	6.51e-05	0.000153	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TNF—Behcet's disease	6.43e-05	0.000151	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APOA1—Behcet's disease	6.42e-05	0.000151	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APOB—Behcet's disease	6.37e-05	0.00015	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APOA1—Behcet's disease	6.33e-05	0.000149	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—SERPINE1—Behcet's disease	6.29e-05	0.000148	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APOB—Behcet's disease	6.28e-05	0.000148	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-B—Behcet's disease	6.27e-05	0.000147	CbGpPWpGaD
Crizotinib—JAK2—Disease—APOB—Behcet's disease	6.26e-05	0.000147	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APOA1—Behcet's disease	6.05e-05	0.000142	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—NOS3—Behcet's disease	6.01e-05	0.000141	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APOB—Behcet's disease	5.95e-05	0.00014	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APOA1—Behcet's disease	5.87e-05	0.000138	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APOB—Behcet's disease	5.78e-05	0.000136	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SERPINE1—Behcet's disease	5.72e-05	0.000134	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-B—Behcet's disease	5.49e-05	0.000129	CbGpPWpGaD
Crizotinib—LCK—Disease—APOB—Behcet's disease	5.48e-05	0.000129	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NOS3—Behcet's disease	5.46e-05	0.000128	CbGpPWpGaD
Crizotinib—LYN—Immune System—ICAM1—Behcet's disease	5.44e-05	0.000128	CbGpPWpGaD
Crizotinib—ABL1—Immune System—ICAM1—Behcet's disease	5.42e-05	0.000127	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—Behcet's disease	5.21e-05	0.000123	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CXCL8—Behcet's disease	5.2e-05	0.000122	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—Behcet's disease	5.19e-05	0.000122	CbGpPWpGaD
Crizotinib—TYK2—Disease—SERPINE1—Behcet's disease	5.18e-05	0.000122	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	5.13e-05	0.000121	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SERPINE1—Behcet's disease	5.09e-05	0.00012	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ICAM1—Behcet's disease	5.09e-05	0.00012	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APOA1—Behcet's disease	5.04e-05	0.000118	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SERPINE1—Behcet's disease	5.02e-05	0.000118	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APOA1—Behcet's disease	4.97e-05	0.000117	CbGpPWpGaD
Crizotinib—TYK2—Disease—NOS3—Behcet's disease	4.95e-05	0.000116	CbGpPWpGaD
Crizotinib—JAK2—Disease—APOA1—Behcet's disease	4.95e-05	0.000116	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—Behcet's disease	4.88e-05	0.000115	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NOS3—Behcet's disease	4.86e-05	0.000114	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-B—Behcet's disease	4.86e-05	0.000114	CbGpPWpGaD
Crizotinib—SRC—Disease—APOB—Behcet's disease	4.85e-05	0.000114	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CXCL8—Behcet's disease	4.84e-05	0.000114	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SERPINE1—Behcet's disease	4.81e-05	0.000113	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NOS3—Behcet's disease	4.79e-05	0.000113	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	4.78e-05	0.000113	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APOA1—Behcet's disease	4.71e-05	0.000111	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOB—Behcet's disease	4.68e-05	0.00011	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SERPINE1—Behcet's disease	4.66e-05	0.00011	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NOS3—Behcet's disease	4.59e-05	0.000108	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APOA1—Behcet's disease	4.57e-05	0.000108	CbGpPWpGaD
Crizotinib—LCK—Immune System—ICAM1—Behcet's disease	4.46e-05	0.000105	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NOS3—Behcet's disease	4.45e-05	0.000105	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOB—Behcet's disease	4.38e-05	0.000103	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CXCL8—Behcet's disease	4.34e-05	0.000102	CbGpPWpGaD
Crizotinib—LCK—Disease—APOA1—Behcet's disease	4.34e-05	0.000102	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CXCL8—Behcet's disease	4.31e-05	0.000101	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CXCL8—Behcet's disease	4.25e-05	0.0001	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CXCL8—Behcet's disease	4.07e-05	9.57e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	4.06e-05	9.55e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SERPINE1—Behcet's disease	4e-05	9.4e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—ICAM1—Behcet's disease	3.95e-05	9.29e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CXCL8—Behcet's disease	3.95e-05	9.28e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CXCL8—Behcet's disease	3.94e-05	9.28e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SERPINE1—Behcet's disease	3.94e-05	9.27e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—SERPINE1—Behcet's disease	3.93e-05	9.24e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—APOA1—Behcet's disease	3.84e-05	9.03e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOB—Behcet's disease	3.84e-05	9.02e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NOS3—Behcet's disease	3.82e-05	8.98e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—Behcet's disease	3.78e-05	8.89e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NOS3—Behcet's disease	3.76e-05	8.85e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS3—Behcet's disease	3.75e-05	8.82e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SERPINE1—Behcet's disease	3.74e-05	8.8e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APOA1—Behcet's disease	3.7e-05	8.71e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SERPINE1—Behcet's disease	3.63e-05	8.54e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NOS3—Behcet's disease	3.57e-05	8.4e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NOS3—Behcet's disease	3.47e-05	8.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APOA1—Behcet's disease	3.47e-05	8.15e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—SERPINE1—Behcet's disease	3.44e-05	8.09e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOB—Behcet's disease	3.4e-05	7.99e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—Behcet's disease	3.39e-05	7.96e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—Behcet's disease	3.34e-05	7.85e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS3—Behcet's disease	3.29e-05	7.73e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CAT—Behcet's disease	3.28e-05	7.72e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOB—Behcet's disease	3.18e-05	7.49e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—Behcet's disease	3.17e-05	7.45e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—Behcet's disease	3.07e-05	7.23e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—Behcet's disease	3.05e-05	7.17e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APOA1—Behcet's disease	3.04e-05	7.14e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—Behcet's disease	2.94e-05	6.92e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS3—Behcet's disease	2.91e-05	6.84e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NOS3—Behcet's disease	2.81e-05	6.6e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—Behcet's disease	2.75e-05	6.47e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APOA1—Behcet's disease	2.69e-05	6.32e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NOS3—Behcet's disease	2.63e-05	6.18e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOA1—Behcet's disease	2.52e-05	5.93e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—Behcet's disease	2.49e-05	5.86e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAT—Behcet's disease	2.48e-05	5.82e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	2.41e-05	5.67e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOB—Behcet's disease	2.4e-05	5.65e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—Behcet's disease	2.33e-05	5.48e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOS3—Behcet's disease	2.3e-05	5.41e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—Behcet's disease	2.13e-05	5.02e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—Behcet's disease	2.04e-05	4.8e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOS3—Behcet's disease	2.04e-05	4.79e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NOS3—Behcet's disease	1.91e-05	4.49e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOA1—Behcet's disease	1.9e-05	4.47e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—Behcet's disease	1.81e-05	4.25e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAT—Behcet's disease	1.53e-05	3.59e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOB—Behcet's disease	1.48e-05	3.48e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NOS3—Behcet's disease	1.44e-05	3.39e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.17e-05	2.76e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NOS3—Behcet's disease	8.88e-06	2.09e-05	CbGpPWpGaD
